Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

PET Radiomics Discriminate Among Different Lymphoma Sub-Types

Stephane Chauvie, Lale Kostakoglu Shields, Luca Guerra, Annibale Versari, Federico Fallanca, Michele Gregianin, Fabrizio Bergesio, Enrica Bergalla, Adriano De Maggi, Denis Sahin, Rexhep Durmo, Umberto Vitolo, Massimo Federico, Andrea Gallamini, Alessandro Rambaldi, Stefano Luminari

Blood (2024) 144 (Supplement 1): 7505.

https://doi.org/10.1182/blood-2024-205170

Published: 2024

Journal Articles

Transcriptomic Profiling Reveals Key Biomarkers in Primary Refractory and Early Relapse Classical Hodgkin Lymphoma

Tanja Lazic, Benedetta Donati, Maria Elena Nizzoli, Alberto Bavieri, Rexhep Durmo, Riccardo Valli, Attilio Gennaro, Cristian Ascione, Alessia Ruffini, Stefano Pozzi, Annibale Versari, Francesco Merli, Stefano Luminari, Alessia Ciarrocchi

Blood (2024) 144 (Supplement 1): 6205.

https://doi.org/10.1182/blood-2024-207696

Published: 2024

Journal Articles

The Prognostic Value of MTV Is Retained in New Proposed SUV 4 Threshold: An International Comparison of Follicular and Hodgkin Patient Survival

Stephane Chauvie, Luca Guerra, Federico Fallanca, Michele Gregianin, Annibale Versari, Rexhep Durmo, Fabrizio Bergesio, Adriano De Maggi, Enrica Bergalla, Alessandro Rambaldi, Simone Ferrero, Caterina Patti, Massimo Federico, Andrea Gallamini, Stefano Luminari

Blood (2024) 144 (Supplement 1): 6254.

https://doi.org/10.1182/blood-2024-206736

Published: 2024

Journal Articles

Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma

Emanuele Zucca, Luca Ceriani, Andrew S. Davies, Giovannino Ciccone, Umberto Ricardi, Alice Di Rocco, Iryna Kryachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Vittorio Ruggero Zilioli, Sara Usai, Luca Arcaini, Elsa Pennese, Anna Dabrowska-Iwanicka, Andrés José María Ferreri, Franceso Merli, Wei Li Zhao, David Hodgson, Codruta Ionescu, Luigi Rigacci, Claudia Cellini, Caterina Stelitano, Stefano Volpetti, Carla Minoia, Michele Spina, Alexander Fossa, George Mikhaeel, Kate Cwynarski, Andrea Janikova, Yana Stepanishyna, Mats Jerkeman, Andreas Huettmann, Maria Gomes da Silva, Don A. Stevens, Sally F Barrington, Bogdan Małkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Oreste Bagni, Kelly Cozens, Sonia Perticone, Nicoletta Ielmini, Letizia Deantonio, Jan Walewski, Marek Trneny, Mary Gospodarowicz, Franco Cavalli, Peter Johnson, Maurizio Martelli

Blood (2023) 142 (Supplement 1): 1718.

https://doi.org/10.1182/blood-2023-174093

Published: 2023

Journal Articles

Total Metabolic Tumor Volume Is Confirmed As Independent Prognostic Factor in Treatment Naïve Follicular Lymphoma Patients and Can be Combined with FLIPI2 to Improve Prognostic Accuracy. a FOLL12 Substudy By the Fondazione Italiana Linfomi

Blood (2022) 140 (Supplement 1): 1313–1315.

https://doi.org/10.1182/blood-2022-166225

Published: 2022

Journal Articles

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL)

Blood (2021) 138 (Supplement 1): 811.

https://doi.org/10.1182/blood-2021-148581

Published: 2021

Journal Articles

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-137412

Published: 2020

Journal Articles

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Blood (2019) 134 (Supplement_1): 4321.

https://doi.org/10.1182/blood-2019-125134

Published: 2019

Journal Articles

Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Joined Analysis of Two Prospective Randomized Phase III Trials

Blood (2018) 132 (Supplement 1): 257.

https://doi.org/10.1182/blood-2018-99-111321

Published: 2018

Journal Articles

Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study

Anne Ségolène Cottereau, Annibale Versari, Stefano Luminari, Jehan Dupuis, Loïc Chartier, René-Olivier Casasnovas, Alina Berriolo-Riedinger, Massimo Menga, Corinne Haioun, Hervé Tilly, Vittoria Tarantino, Massimo Federico, Gilles Salles, Judith Trotman, Michel Meignan

Blood (2018) 131 (22): 2449–2453.

https://doi.org/10.1182/blood-2017-11-816298

Published: 2018

Includes: Supplemental data

Journal Articles

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial

Blood (2018) 131 (13): 1456–1463.

https://doi.org/10.1182/blood-2017-07-795476

Published: 2018

Includes: Supplemental data

Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Blood (2017) 130 (Supplement 1): 736.

https://doi.org/10.1182/blood.V130.Suppl_1.736.736

Published: 2017

Journal Articles

Low Suvmax Measured on Baseline FDG-PET/CT and Elevated β2 Microglobulin Are Negative Predictors of Outcome in High Tumor Burden Follicular Lymphoma Treated By Immunochemotherapy: A Pooled Analysis of Three Prospective Studies

Anne Ségolène Cottereau, MD, Annibale Versari, MD, Loïc Chartier, Jehan Dupuis, MD, Vittoria Tarantino, MD, Rene-Olivier Casasnovas, MD, Antonella Franceschetto, Emmanuel Itti, MD PhD, Hervé Tilly, MD PhD, Corinne Haioun, MD, Massimo Federico, MD PhD, Alina Berriolo, MD, Gilles Andre Salles, MD PhD, Stefano Luminari, Michel Meignan, MD PhD, Judith Trotman, MBChB

Blood (2016) 128 (22): 1101.

https://doi.org/10.1182/blood.V128.22.1101.1101

Published: 2016

Journal Articles

Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial

Blood (2016) 128 (22): 184.

https://doi.org/10.1182/blood.V128.22.184.184

Published: 2016

Journal Articles

Prospective Evaluation of 18F-FDG PET/CT As Predictor of Prognosis in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results from the Imaging Sus-Study of the EMN02/HO95 MM Randomized Phase III Trial

Blood (2016) 128 (22): 992.

https://doi.org/10.1182/blood.V128.22.992.992

Published: 2016

Journal Articles

PET-Based Textural Analysis Assessment in Early Stage Hodgkin Lymphoma Treated with Standard Combined Approach

Angelo Fama, MD, Patrizia Ciammella, MD, Massimiliano Casali, MD, Elisa Barbolini, PhD, Ala Podgornii, MD, Mauro Iori, PhD, Annibale Versari, MD, Franceso Merli, MD, Giacomo Feliciani, MD

Blood (2015) 126 (23): 3949.

https://doi.org/10.1182/blood.V126.23.3949.3949

Published: 2015

Journal Articles

Baseline Metabolic Tumour Volume Predicts Outcome in High Tumor Burden Follicular Lymphoma. A Pooled Analysis of Three Multicenter Studies

Michel Meignan, Annibale Versari, MD, Anne Ségolène Cottereau, Loïc Chartier, Jehan Dupuis, MD, Sami Boussetta, Ilaria Grassi, Rene-Olivier Casasnovas, MD, Corinne Haioun, MD PhD, Hervé Tilly, MD PhD, Massimo Federico, Gilles A. Salles, MD PhD, Stefano Luminari, MD, Judith Trotman, MBChB

Blood (2015) 126 (23): 3919.

https://doi.org/10.1182/blood.V126.23.3919.3919

Published: 2015

Journal Articles

The Role Of Qualitative FDG-PET Assessment Using The 5 Point Deauville Scale For Postinduction Response Assessment In Patients With Follicular Lymphoma. A Study From The Fondazione Italiana Linfomi (FIL)

Stefano Luminari, MD, Annibale Versari, MD, Antonella Franceschetto, MD, Simona Peano, Stephan Chauvie, Fabrizio Bergesio, Carola Boccomini, MD, Alessandra Tucci, MD, Francesco Merli, MD, Chiara Rusconi, MD, Flavia Salvi, MD, Alessandra Dondi, Massimo Federico, MD

Blood (2013) 122 (21): 4295.

https://doi.org/10.1182/blood.V122.21.4295.4295

Published: 2013

Journal Articles

Baseline Metabolic Tumor Volume Is Predictive of Patient Outcome in Diffuse Large B Cell Lymphoma

Rene-Olivier Casasnovas, MD, Myriam Sasanelli, MD, Alina Berriolo-Riedinger, MD, Franck Morschhauser, MD, PhD, Emmanuel Itti, MD, PhD, Damien Huglo, MD, PhD, Annibale Versari, MD, Bertrand Coiffier, MD, PhD, Michel Meignan, MD, PhD

Blood (2012) 120 (21): 1598.

https://doi.org/10.1182/blood.V120.21.1598.1598

Published: 2012

Journal Articles

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

Marc PE André, MD, Oumedaly Reman, MD, Massimo Federico, MD, Théodore Girinski, MD, Pauline Brice, MD, Ercole Brusamolino, MD, Christophe Ferme, MD, Richard vander Maazen, MD, Monica Bellei, Catherine Sebban, MD, Franck Morschhauser, MD, PhD, Elly Lugtenburg, MD, PhD, Aspasia Stamatoulas, MD, Catherine Fortpied, Msc, Michel Meignan, MD, PhD, Annibale Versari, MD, Martin Hutchings, MD, John Raemaekers, MD

Blood (2012) 120 (21): 549.

https://doi.org/10.1182/blood.V120.21.549.549

Published: 2012

NARROW

PET Radiomics Discriminate Among Different Lymphoma Sub-Types

Transcriptomic Profiling Reveals Key Biomarkers in Primary Refractory and Early Relapse Classical Hodgkin Lymphoma

The Prognostic Value of MTV Is Retained in New Proposed SUV 4 Threshold: An International Comparison of Follicular and Hodgkin Patient Survival

Survival Patterns of Non-Randomized Patients in the IELSG37 Study: Deauville Score 4 Is Not Necessarily Associated with Poor Outcome in Primary Mediastinal Lymphoma

Total Metabolic Tumor Volume Is Confirmed As Independent Prognostic Factor in Treatment Naïve Follicular Lymphoma Patients and Can be Combined with FLIPI2 to Improve Prognostic Accuracy. a FOLL12 Substudy By the Fondazione Italiana Linfomi

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL)

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Standardization of 18F-FDG PET/CT According to Deauville Criteria for MRD Evaluation in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Joined Analysis of Two Prospective Randomized Phase III Trials

Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Low Suvmax Measured on Baseline FDG-PET/CT and Elevated β2 Microglobulin Are Negative Predictors of Outcome in High Tumor Burden Follicular Lymphoma Treated By Immunochemotherapy: A Pooled Analysis of Three Prospective Studies

Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial

Prospective Evaluation of 18F-FDG PET/CT As Predictor of Prognosis in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results from the Imaging Sus-Study of the EMN02/HO95 MM Randomized Phase III Trial

PET-Based Textural Analysis Assessment in Early Stage Hodgkin Lymphoma Treated with Standard Combined Approach

Baseline Metabolic Tumour Volume Predicts Outcome in High Tumor Burden Follicular Lymphoma. A Pooled Analysis of Three Multicenter Studies

The Role Of Qualitative FDG-PET Assessment Using The 5 Point Deauville Scale For Postinduction Response Assessment In Patients With Follicular Lymphoma. A Study From The Fondazione Italiana Linfomi (FIL)

Baseline Metabolic Tumor Volume Is Predictive of Patient Outcome in Diffuse Large B Cell Lymphoma

Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only